03.07.2015 - Aetna will buy Humana for $ 37 billion

Today, the American corporation Aetna announced future purchase of Humana. The transaction value will be 37 billion US dollars, or 230 per share. It is worth noting the positive effect of assets consolidation of two companies, which will help to reduce costs and increase revenue amid growing activity on the market of mergers and acquisitions in the sector, which remains in the leaders of growth for several years. We expect continued growth in the company's shares after the completion of the transaction and recommend holding these shares in the long-term portfolio with growth potential by 25-27% per annum.

Aetna Symbol

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.